Actiq and the more potent opioid Fentora, are drugs approved by the Food and Drug Administration (FDA) specifically for cancer patients currently on around-the-clock opioid treatment who experience breakthrough pain. The drugs are given in the form of a lollipop lozenge. But Cephalon, the maker of Actiq and Fentora, has been investigated by the FDA for promoting an off-label use of the drug for the treatment of headaches, backaches and injuries. In this video, 40-year-old Mark, who began taking Actiq for headaches, describes his experience in ending his addiction to the powerful painkiller.

Recorded: March 30, 2010

Courtesy of: VIDEO DIARIES

Keywords: Pharmaceutical, Actiq and Fentora